Chronic myelogenous leukemia maintains specific CD8+ T cells through IL-7 signaling

European Journal of Immunology

Volumn 40, Issue 10, 2010, Pages 2720-2730

  Mumprecht, Sabine ^a   Schürch, Christian ^a   Scherrer, Sandro ^a   Claus, Christina ^a   Ochsenbein, Adrian F ^a,b  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

CD8+ T cells; Chronic myelogenous leukemia; IL 7 signaling

Indexed keywords

INTERLEUKIN 7; INTERLEUKIN 7 RECEPTOR ALPHA; LEUKEMIA ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; CD8+ T LYMPHOCYTE; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; DISEASE CONTROL; DISEASE COURSE; IMMUNE RESPONSE; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; DISEASE MODELS, ANIMAL; FLOW CYTOMETRY; INTERLEUKIN-7; KAPLAN-MEIER ESTIMATE; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; RECEPTORS, INTERLEUKIN-7; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, CYTOTOXIC;

EID: 77957167070     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201040404     Document Type: Article

References (44)

1. Zhang, X. and Ren, R., Bcr-Abl efficiently induces a myeloproliferative disease and production of excess interleukin-3 and granulocyte-macrophage colony-stimulating factor in mice: a novel model for chronic myelogenous leukemia. Blood 1998. 92: 3829-3840. (Pubitemid 28525209)
2. Ren, R., Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukaemia. Nat. Rev. Cancer 2005. 5: 172-183.
3. Shet, A. S., Jahagirdar, B. N. and Verfaillie, C. M., Chronic myelogenous leukemia: mechanisms underlying disease progression. Leukemia 2002. 16: 1402-1411.
4. Apperley, J. F., Jones, L., Hale, G., Waldmann, H., Hows, J., Rombos, Y., Tsatalas, C. et al., Bone marrow transplantation for patients with chronic myeloid leukaemia: T-cell depletion with Campath-1 reduces the incidence of graft-versus-host disease but may increase the risk of leukaemic relapse. Bone Marrow Transplant. 1986. 1: 53-66. (Pubitemid 17070365)
5. Kolb, H. J., Schattenberg, A., Goldman, J. M., Hertenstein, B., Jacobsen, N., Arcese, W., Ljungman, P. et al., Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. Blood 1995. 86: 2041-2050.
6. Rezvani, K., Grube, M., Brenchley, J. M., Sconocchia, G., Fujiwara, H., Price, D. A., Gostick, E. et al., Functional leukemia-associated antigen-specific memory CD8+T cells exist in healthy individuals and in patients with chronic myelogenous leukemia before and after stem cell transplantation. Blood 2003. 102: 2892-2900. (Pubitemid 37248862)
7. Molldrem, J. J., Lee, P. P., Kant, S., Wieder, E., Jiang, W., Lu, S., Wang, C. and Davis, M. M., Chronic myelogenous leukemia shapes host immunity by selective deletion of high-avidity leukemia-specific T cells. J. Clin. Invest. 2003. 111: 639-647.
8. Schluns, K. S., Kieper, W. C., Jameson, S. C. and Lefrancois, L., Interleukin-7 mediates the homeostasis of naive and memory CD8 T cells in vivo. Nat. Immunol. 2000. 1: 426-432.
9. Ku, C. C., Murakami, M., Sakamoto, A., Kappler, J. and Marrack, P., Control of homeostasis of CD8+memory T cells by opposing cytokines. Science 2000. 288: 675-678. (Pubitemid 30241571)
10. Kaech, S. M., Tan, J. T., Wherry, E. J., Konieczny, B. T., Surh, C. D. and Ahmed, R., Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells. Nat. Immunol. 2003. 4: 1191-1198.
11. Alpdogan, O. and van den Brink, M. R., IL-7 and IL-15: therapeutic cytokines for immunodeficiency. Trends Immunol. 2005. 26: 56-64.
12. Noguchi, M., Nakamura, Y., Russell, S. M., Ziegler, S. F., Tsang, M., Cao, X. and Leonard, W. J., Interleukin-2 receptor gamma chain: a functional component of the interleukin-7 receptor. Science 1993. 262: 1877-1880.
13. Alpdogan, O., Schmaltz, C., Muriglan, S. J., Kappel, B. J., Perales, M. A., Rotolo, J. A., Halm, J. A. et al., Administration of interleukin-7 after allogeneic bone marrow transplantation improves immune reconstitution without aggravating graft-versus-host disease. Blood 2001. 98: 2256-2265.
14. Bolotin, E., Smogorzewska, M., Smith, S., Widmer, M. and Weinberg, K., Enhancement of thymopoiesis after bone marrow transplant by in vivo interleukin-7. Blood 1996. 88: 1887-1894. (Pubitemid 26307089)
15. Abdul-Hai, A., Or, R., Slavin, S., Friedman, G., Weiss, L., Matsa, D. and Ben-Yehuda, A., Stimulation of immune reconstitution by interleukin-7 after syngeneic bone marrow transplantation in mice. Exp. Hematol. 1996. 24: 1416-1422.
16. Abdul-Hai, A., Weiss, L., Ben-Yehuda, A., Ergas, D., Shapira, M. Y. and Slavin, S., Interleukin-7 induced facilitation of immunological reconstitution of sublethally irradiated mice following treatment with alloreactive spleen cells in a murine model of B-cell leukemia/lymphoma (BCL1). Bone Marrow Transplant. 2007. 40: 881-889. (Pubitemid 350020324)
17. Mumprecht, S., Schürch, C., Schwaller, J., Solenthaler, M. and Ochsenbein, A. F., PD-1 signaling on chronic myeloid leukemia-specific T cells results in T cell exhaustion and disease progression. Blood 2009. 114: 1528-1536..
18. Obar, J. J., Khanna, K. M. and Lefrancois, L., Endogenous naive CD8+T cell precursor frequency regulates primary and memory responses to infection. Immunity 2008. 28: 859-869.
19. Moskophidis, D., Lechner, F., Pircher, H. and Zinkernagel, R. M., Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells. Nature 1993. 362: 758-761.
20. Molldrem, J. J., Lee, P. P., Wang, C., Felio, K., Kantarjian, H. M., Champlin, R. E. and Davis, M. M., Evidence that specific T lymphocytes may participate in the elimination of chronic myelogenous leukemia. Nat. Med. 2000. 6: 1018-1023.
21. Zajac, A. J., Blattman, J. N., Murali-Krishna, K., Sourdive, D. J., Suresh, M., Altman, J. D. and Ahmed, R., Viral immune evasion due to persistence of activated T cells without effector function. J. Exp. Med. 1998. 188: 2205-2213.
22. Gallimore, A., Glithero, A., Godkin, A., Tissot, A. C., Pluckthun, A., Elliott, T., Hengartner, H. and Zinkernagel, R., Induction and exhaustion of lymphocytic choriomeningitis virus-specific cytotoxic T lymphocytes visualized using soluble tetrameric major histocompatibility complex class I-peptide complexes. J. Exp. Med. 1998. 187: 1383-1393.
23. Shankar, P., Russo, M., Harnisch, B., Patterson, M., Skolnik, P. and Lieberman, J., Impaired function of circulating HIV-specific CD8(+) T cells in chronic human immunodeficiency virus infection. Blood 2000. 96: 3094-3101.
24. Wedemeyer, H., He, X. S., Nascimbeni, M., Davis, A. R., Greenberg, H. B., Hoofnagle, J. H., Liang, T. J. et al., Impaired effector function of hepatitis C virus-specific CD8+T cells in chronic hepatitis C virus infection. J. Immunol. 2002. 169: 3447-3458.
25. Gruener, N. H., Lechner, F., Jung, M. C., Diepolder, H., Gerlach, T., Lauer, G., Walker, B. et al., Sustained dysfunction of antiviral CD8+ T lymphocytes after infection with hepatitis C virus. J. Virol. 2001. 75: 5550-5558.
26. Reignat, S., Webster, G. J., Brown, D., Ogg, G. S., King, A., Seneviratne, S. L., Dusheiko, G. et al., Escaping high viral load exhaustion: CD8 cells with altered tetramer binding in chronic hepatitis B virus infection. J. Exp. Med. 2002. 195: 1089-1101.
27. Barry, A. P., Silvestri, G., Safrit, J. T., Sumpter, B., Kozyr, N., McClure, H. M., Staprans, S. I. and Feinberg, M. B., Depletion of CD8+cells in sooty mangabey monkeys naturally infected with simian immunodeficiency virus reveals limited role for immune control of virus replication in a natural host species. J. Immunol. 2007. 178: 8002-8012.
28. Tan, J. T., Ernst, B., Kieper, W. C., LeRoy, E., Sprent, J. and Surh, C. D., Interleukin (IL)-15 and IL-7 jointly regulate homeostatic proliferation of memory phenotype CD8+cells but are not required for memory phenotype CD4+cells. J. Exp. Med. 2002. 195: 1523-1532.
29. Schober, S. L., Kuo, C. T., Schluns, K. S., Lefrancois, L., Leiden, J. M. and Jameson, S. C., Expression of the transcription factor lung Kruppel-like factor is regulated by cytokines and correlates with survival of memory T cells in vitro and in vivo. J. Immunol. 1999. 163: 3662-3667.
30. Lang, K. S., Recher, M., Navarini, A. A., Harris, N. L., Lohning, M., Junt, T., Probst, H. C. et al., Inverse correlation between IL-7 receptor expression and CD8 T cell exhaustion during persistent antigen stimulation. Eur. J. Immunol. 2005. 35: 738-745.
31. Koesters, S. A., Alimonti, J. B., Wachihi, C., Matu, L., Anzala, O., Kimani, J., Embree, J. E. et al., IL-7Ralpha expression on CD4+T lymphocytes decreases with HIV disease progression and inversely correlates with immune activation. Eur. J. Immunol. 2006. 36: 336-344.
32. Urbani, S., Amadei, B., Tola, D., Massari, M., Schivazappa, S., Missale, G. and Ferrari, C., PD-1 expression in acute hepatitis C virus (HCV) infection is associated with HCV-specific CD8 exhaustion. J. Virol. 2006. 80: 11398-11403.
33. Wolthers, K. C., Otto, S. A., Lens, S. M., Kolbach, D. N., van Lier, R. A., Miedema, F. and Meyaard, L., Increased expression of CD80, CD86 and CD70 on T cells from HIV-infected individuals upon activation in vitro: regulation by CD4+T cells. Eur. J. Immunol. 1996. 26: 1700-1706.
34. Ochsenbein, A. F., Riddell, S. R., Brown, M., Corey, L., Baerlocher, G. M., Lansdorp, P. M. and Greenberg, P. D., CD27 expression promotes longterm survival of functional effector-memory CD8+cytotoxic T lymphocytes in HIV-infected patients. J. Exp. Med. 2004. 200: 1407-1417.
35. Matter, M., Mumprecht, S., Pinschewer, D. D., Pavelic, V., Yagita, H., Krautwald, S., Borst, J. and Ochsenbein, A. F., Virus-induced polyclonal B cell activation improves protective CTL memory via retained CD27 expression on memory CTL. Eur. J. Immunol. 2005. 35: 3229-3239.
36. Matter, M. S., Claus, C. and Ochsenbein, A. F., CD4+T cell help improves CD8+T cell memory by retained CD27 expression. Eur. J. Immunol. 2008. 38: 1847-1856.
37. Pircher, H., Burki, K., Lang, R., Hengartner, H. and Zinkernagel, R. M., Tolerance induction in double specific T-cell receptor transgenic mice varies with antigen. Nature 1989. 342: 559-561.
38. Ehl, S., Hombach, J., Aichele, P., Rulicke, T., Odermatt, B., Hengartner, H., Zinkernagel, R. and Pircher, H., Viral and bacterial infections interfere with peripheral tolerance induction and activate CD8+T cells to cause immunopathology. J. Exp. Med. 1998. 187: 763-774.
39. von Freeden-Jeffry, U., Vieira, P., Lucian, L. A., McNeil, T., Burdach, S. E. and Murray, R., Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine. J. Exp. Med. 1995. 181: 1519-1526.
40. Mumprecht, S., Matter, M., Pavelic, V. and Ochsenbein, A. F., Imatinib mesylate selectively impairs expansion of memory cytotoxic T cells without affecting the control of primary viral infections. Blood 2006. 108: 3406-3413.
41. Matter, M., Odermatt, B., Yagita, H., Nuoffer, J. M. and Ochsenbein, A. F., Elimination of chronic viral infection by blocking CD27 signaling. J. Exp. Med. 2006. 203: 2145-2155.
42. Hawley, R. G., Lieu, F. H., Fong, A. Z. and Hawley, T. S., Versatile retroviral vectors for potential use in gene therapy. Gene Ther. 1994. 1: 136-138.
43. Persons, D. A., Allay, J. A., Allay, E. R., Smeyne, R. J., Ashmun, R. A., Sorrentino, B. P. and Nienhuis, A. W., Retroviral-mediated transfer of the green fluorescent protein gene into murine hematopoietic cells facilitates scoring and selection of transduced progenitors in vitro and identification of genetically modified cells in vivo. Blood 1997. 90: 1777-1786.
44. Finer, M. H., Dull, T. J., Qin, L., Farson, D. and Roberts, M. R., kat: a high-efficiency retroviral transduction system for primary human T lymphocytes. Blood 1994. 83: 43-50.